These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 35967738)
41. Cell membrane-coated nanosized active targeted drug delivery systems homing to tumor cells: A review. He Z; Zhang Y; Feng N Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110298. PubMed ID: 31753336 [TBL] [Abstract][Full Text] [Related]
42. Cell Membrane-Coated Biomimetic Nanoparticles in Cancer Treatment. Zhang S; Zhang X; Gao H; Zhang X; Sun L; Huang Y; Zhang J; Ding B Pharmaceutics; 2024 Apr; 16(4):. PubMed ID: 38675192 [TBL] [Abstract][Full Text] [Related]
43. Co-delivery of Docetaxel and Disulfonate Tetraphenyl Chlorin in One Nanoparticle Produces Strong Synergism between Chemo- and Photodynamic Therapy in Drug-Sensitive and -Resistant Cancer Cells. Gaio E; Conte C; Esposito D; Miotto G; Quaglia F; Moret F; Reddi E Mol Pharm; 2018 Oct; 15(10):4599-4611. PubMed ID: 30148955 [TBL] [Abstract][Full Text] [Related]
44. Targeted delivery and enhanced uptake of chemo-photodynamic nanomedicine for melanoma treatment. Huang X; Mu N; Ding Y; Lam HW; Yue L; Gao C; Chen T; Yuan Z; Wang R Acta Biomater; 2022 Jul; 147():356-365. PubMed ID: 35577046 [TBL] [Abstract][Full Text] [Related]
45. Mesenchymal stem cells: a potential targeted-delivery vehicle for anti-cancer drug, loaded nanoparticles. Gao Z; Zhang L; Hu J; Sun Y Nanomedicine; 2013 Feb; 9(2):174-84. PubMed ID: 22772046 [TBL] [Abstract][Full Text] [Related]
46. Stem-Cell-Membrane Camouflaging on Near-Infrared Photoactivated Upconversion Nanoarchitectures for in Vivo Remote-Controlled Photodynamic Therapy. Gao C; Lin Z; Wu Z; Lin X; He Q ACS Appl Mater Interfaces; 2016 Dec; 8(50):34252-34260. PubMed ID: 27936561 [TBL] [Abstract][Full Text] [Related]
47. Cell membrane-coated nanoparticles: research advances. Zou S; Wang B; Wang C; Wang Q; Zhang L Nanomedicine (Lond); 2020 Mar; 15(6):625-641. PubMed ID: 32098564 [TBL] [Abstract][Full Text] [Related]
48. Light-activatable Chlorin e6 (Ce6)-imbedded erythrocyte membrane vesicles camouflaged Prussian blue nanoparticles for synergistic photothermal and photodynamic therapies of cancer. Sun L; Li Q; Hou M; Gao Y; Yang R; Zhang L; Xu Z; Kang Y; Xue P Biomater Sci; 2018 Oct; 6(11):2881-2895. PubMed ID: 30192355 [TBL] [Abstract][Full Text] [Related]
49. One-pot preparation of hyaluronic acid-coated iron oxide nanoparticles for magnetic hyperthermia therapy and targeting CD44-overexpressing cancer cells. Soleymani M; Velashjerdi M; Shaterabadi Z; Barati A Carbohydr Polym; 2020 Jun; 237():116130. PubMed ID: 32241421 [TBL] [Abstract][Full Text] [Related]
50. Co-delivery of Sorafenib and CRISPR/Cas9 Based on Targeted Core-Shell Hollow Mesoporous Organosilica Nanoparticles for Synergistic HCC Therapy. Zhang BC; Luo BY; Zou JJ; Wu PY; Jiang JL; Le JQ; Zhao RR; Chen L; Shao JW ACS Appl Mater Interfaces; 2020 Dec; 12(51):57362-57372. PubMed ID: 33301289 [TBL] [Abstract][Full Text] [Related]
51. Erythrocyte-platelet hybrid membranes coating polypyrrol nanoparticles for enhanced delivery and photothermal therapy. Liu Y; Wang X; Ouyang B; Liu X; Du Y; Cai X; Guo H; Pang Z; Yang W; Shen S J Mater Chem B; 2018 Nov; 6(43):7033-7041. PubMed ID: 32254586 [TBL] [Abstract][Full Text] [Related]
52. Erythrocyte membrane-camouflaged gefitinib/albumin nanoparticles for tumor imaging and targeted therapy against lung cancer. Wen Q; Zhang Y; Muluh TA; Xiong K; Wang B; Lu Y; Wu Z; Liu Y; Shi H; Xiao S; Fu S Int J Biol Macromol; 2021 Dec; 193(Pt A):228-237. PubMed ID: 34688683 [TBL] [Abstract][Full Text] [Related]
53. Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy. Gong C; Yu X; You B; Wu Y; Wang R; Han L; Wang Y; Gao S; Yuan Y J Nanobiotechnology; 2020 Jun; 18(1):92. PubMed ID: 32546174 [TBL] [Abstract][Full Text] [Related]
54. Magnetic Nanoparticles Labeled Mesenchymal Stem Cells: A Pragmatic Solution toward Targeted Cancer Theranostics. Singh A; Jain S; Senapati S; Verma RS; Sahoo SK Adv Healthc Mater; 2015 Oct; 4(14):2078-2089. PubMed ID: 26332511 [TBL] [Abstract][Full Text] [Related]
55. Biomimetic Nanoparticles Camouflaged in Cancer Cell Membranes and Their Applications in Cancer Theranostics. Jin J; Bhujwalla ZM Front Oncol; 2019; 9():1560. PubMed ID: 32039028 [TBL] [Abstract][Full Text] [Related]
56. CRPC Membrane-Camouflaged, Biomimetic Nanosystem for Overcoming Castration-Resistant Prostate Cancer by Cellular Vehicle-Aided Tumor Targeting. Lu K; Li Z; Hu Q; Sun J; Chen M Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408983 [TBL] [Abstract][Full Text] [Related]
57. Cell membrane-camouflaged inorganic nanoparticles for cancer therapy. Song W; Jia P; Zhang T; Dou K; Liu L; Ren Y; Liu F; Xue J; Hasanin MS; Qi H; Zhou Q J Nanobiotechnology; 2022 Jun; 20(1):289. PubMed ID: 35717234 [TBL] [Abstract][Full Text] [Related]
58. Delicately Designed Cancer Cell Membrane-Camouflaged Nanoparticles for Targeted Li S; Jiang W; Yuan Y; Sui M; Yang Y; Huang L; Jiang L; Liu M; Chen S; Zhou X ACS Appl Mater Interfaces; 2020 Dec; 12(51):57290-57301. PubMed ID: 33231083 [TBL] [Abstract][Full Text] [Related]
59. Platelet membrane camouflaged nanoparticles: Biomimetic architecture for targeted therapy. Kunde SS; Wairkar S Int J Pharm; 2021 Apr; 598():120395. PubMed ID: 33639226 [TBL] [Abstract][Full Text] [Related]
60. Cell membrane camouflaged biomimetic nanoparticles: Focusing on tumor theranostics. Zhu L; Zhong Y; Wu S; Yan M; Cao Y; Mou N; Wang G; Sun D; Wu W Mater Today Bio; 2022 Mar; 14():100228. PubMed ID: 35265826 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]